These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo. Hu Q, Wang XY, Kang LK, Wei HM, Xu CM, Wang T, Wen ZH. PLoS One; 2016 Jul; 11(2):e0149075. PubMed ID: 26862757 [Abstract] [Full Text] [Related]
4. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS. Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985 [Abstract] [Full Text] [Related]
5. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, Gambhir SS. Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339 [Abstract] [Full Text] [Related]
6. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M. Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118 [Abstract] [Full Text] [Related]
7. Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies. Daeichin V, Kooiman K, Skachkov I, Bosch JG, Theelen TL, Steiger K, Needles A, Janssen BJ, Daemen MJ, van der Steen AF, de Jong N, Sluimer JC. Ultrasound Med Biol; 2016 Sep; 42(9):2283-93. PubMed ID: 27302657 [Abstract] [Full Text] [Related]
8. Long residence time of ultrasound microbubbles targeted to integrin in murine tumor model. Jun HY, Park SH, Kim HS, Yoon KH. Acad Radiol; 2010 Jan; 17(1):54-60. PubMed ID: 19815430 [Abstract] [Full Text] [Related]
9. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Anderson CR, Hu X, Zhang H, Tlaxca J, Declèves AE, Houghtaling R, Sharma K, Lawrence M, Ferrara KW, Rychak JJ. Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825 [Abstract] [Full Text] [Related]
10. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis. Yan F, Xu X, Chen Y, Deng Z, Liu H, Xu J, Zhou J, Tan G, Wu J, Zheng H. Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460 [Abstract] [Full Text] [Related]
11. [Evaluation of tumor angiogenesis using microbubbles conjugated with RGD peptides and contrast enhanced ultrasound]. Hu GQ, Yang L, Xiao YB, Xie JJ, Wu JF, Cai JJ, Liu J, Liao WJ, Bin JP. Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):655-8. PubMed ID: 21122377 [Abstract] [Full Text] [Related]
13. Simplified Preparation of αvβ3 Integrin-Targeted Microbubbles Based on a Clinically Available Ultrasound Contrast Agent: Validation in a Tumor-Bearing Mouse Model. Otani K, Nishimura H, Kamiya A, Harada-Shiba M. Ultrasound Med Biol; 2018 May; 44(5):1063-1073. PubMed ID: 29501282 [Abstract] [Full Text] [Related]
17. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma. Wei S, Fu N, Sun Y, Yang Z, Lei L, Huang P, Yang B. Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557 [Abstract] [Full Text] [Related]